3138 results for «825»
3138 results
Mitral complications
28 Nov 2022 – From PCR London Valves 2022
Because we can all be confronted with unexpected complications, this session of PCR LV 2022 proposes to study 5 specific cases such as an early redo mitral transcatheter edge-to-edge repair after single leaflet detachment or an unexpected cause of worsening dyspnoea after edge-to-edge mitral repair.
Transcatheter mitral valve interventions: clinical outcomes 2
28 Nov 2022 – From PCR London Valves 2022
This PCR LV 2022 session will enable you to discover outcomes of transcatheter edge-to-edge MVR in patients with right ventricle dysfunction, TEER for MR early after myocardial infarction, or a predictive selection of patients for TMVR, among others!
Patient-prosthesis mismatch: surgical and transcatheter approaches - LIVE case
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover different surgical and transcatheter approaches:
- Part 1: Bioprosthesis aortic valve stenosis
A 73-year-old male, with diabetes, BMI 29, atrial fibrillation, history of SAVR 15 years ago (Perimount 27) presents a symptomatic severe surgical valve stenosis with a preserved LV function.
During the live time...
TAVI: technical considerations
28 Nov 2022 – From PCR London Valves 2022
Consult this session on TAVI technical considerations to discover a selection of cases presented during PCR LV 2022: transseptal snaring as a bailout from valvuloplasty balloon entrapment within a self-expanding valve, severe thrombocytopenia and severe aortic stenosis, embolisation of a fully deployed Evolute valve due to chest...
Challenging scenarios: bicuspid aortic valves
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the variety of bicuspid aortic valve phenotypes and their impact on procedural outcomes, the pre-procedural planning and optimal procedural technique in this challenging patient cohort, as well as the key considerations for TAVI in younger patients with a bicuspid aortic valve.
TAVI complications: Session 3
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover how to manage various TAVI complications: complex iliofemoral artery dissection following TAVI, ruptured TAVI balloon, displacement of the transcatheter aortic valve prosthesis, and much more!
How to deal with residual or recurrent mitral regurgitation after failed surgical or transcatheter repair
28 Nov 2022 – From PCR London Valves 2022
Consul this session to learn more about the available treatment options after failed mitral surgical or transcatheter procedures, the factors that increase the likelihood of residual/recurrent mitral regurgitation, and more!
Rapid-fire abstracts: Session 5
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: impact of right ventricular dysfunction on the outcomes of TAVI - Insights from nationwide database, impact of COVID-19 pandemic on TAVI activity: a worldwide registry, redo isolated tricuspid valve surgery - Prediction of...
Challenging scenarios during transcatheter tricuspid valve intervention
28 Nov 2022 – From PCR London Valves 2022
Consult these presentations to get insights into how the reduction of tricuspid valve coaptation gaps can facilitate tricuspid transcatheter edge-to-edge repair, to learn some tips and tricks for improved transoesophageal imaging during tricuspid valve interventions and to master techniques for the management of single leaflet device attachment during this...
Rapid-Fire clinical cases: Session 3
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of clinical cases presented during PCR LV 2022: tunnel stent technique as an alternative treatment for left main protection in valve-in-valve TAVI, coronary embolisation due to valve-in-valve aortic prothesis thrombosis, aortic prosthetic valve dysfunction due to endocarditis, and more!
Innovations in transcatheter tricuspid valve intervention - LIVE case
28 Nov 2022 – From PCR London Valves 2022
Watch two very innovative tricuspid cases you've never seen before:
- Part 1: TR replacement
An 82-year-old male with chronic atrial fibrillation and completely PM dependent for 27 years, presents a symptomatic torrential TR and an enlarged annulus with a great gap. The operators implanted for the first time in...
Rapid-fire abstracts: Session 6
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: hydrodynamic performance of ACURATE neo2 for valve-in-valve across different surgical bioprostheses, impact of leaflets splitting on coronary access after redo TAVI in failed supra-annular platforms, same-day discharge after TF and alternate access...
Challenging scenarios: bioprosthetic valve dysfunction
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the different causes of bioprosthetic valve dysfunction and the best options (surgical, transcatheter or medical) for the management of patients with this kind of dysfunction, as well as to discover how valve design impacts on durability and what the future holds...
Optimal management of right ventricular pacing leads in patients with tricuspid regurgitation
28 Nov 2022 – From PCR London Valves 2022
Consult these presentations to learn more about the consequences of right ventricular pacing lead implantation on tricuspid valve function, the diagnosis and imaging assessment of lead-induced tricuspid regurgitation and the possible treatment options for patients with right ventricular pacing leads and significant tricuspid regurgitation.
Rapid-fire abstracts: Session 7
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: contemporary outcome of high surgical risk mitral regurgitation, quantitative flow ratio vs. FFR for coronary functional evaluation in patients undergoing TAVI, videodensitometric quantification of paravalvular leak after implantation of the new Myval-Octacor,...
Rapid-fire clinical cases: Session 4
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: the buddy wire technique used with three different transcatheter heart valve systems, acute right coronary artery occlusion caused by calcium embolisation during TAVI, off-label temporary left ventricle haemodynamic support via Impella CP...
All you need to know before starting a mitral valve-in-valve or valve-in-ring procedure
29 Nov 2022 – From PCR London Valves 2022
Discover all you need to know before starting a mitral valve-in-valve or valve-in-ring procedure in this session: learn how to evaluate patients with an indication for these procedures, how to identify the risks and determine the choice of prosthesis, the different steps of the procedure using a transseptal approach, and...
Treatment of multi-valve disease
29 Nov 2022 – From PCR London Valves 2022
Get a look at these presentations to learn more about the basic haemodynamic interactions between different valve lesions, the existing surgical standards (and evolving transcatheter standards) for the treatment of multi-valve disease, and to discover a selection of cases that demonstrate the importance of clear indications and appropriate timing...
Mitral edge-to-edge repair: surgical and transcatheter approaches - LIVE case
29 Nov 2022 – From PCR London Valves 2022
Learn from these 2 cases of primary mitral repair using percutaneous and surgical approaches:
- LIVE case - A 90-year-old male with history of LAD PCI 23 years ago and paroxysmal atrial fibrillation presents a primary mitral regurgitation (P2 prolapse) on mildly dilated LV and preserved LV function.
The operators...
Aortic stenosis and concomitant mitral valve disease
29 Nov 2022 – From PCR London Valves 2022
Consult these presentations to better understand how concomitant mitral valve disease influences clinical and procedural outcomes, to differentiate between patients with mitral valve disease that require concomitant therapy and those where conservative treatment is more appropriate and to gain insights into potential interventional options for this disease.
